Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 46 results:
Συντάκτης Τίτλος [ Τύπος] Έτος Φίλτρα: Συντάκτης is Karagiannis, Thomas [Clear All Filters]
Meta-analysis of artificial pancreas trials: methodological considerations.
The Lancet Diabetes & Endocrinology. 5(9), 685.
(2017). Meta-analysis of artificial pancreas trials: methodological considerations..
Lancet Diabetes Endocrinol. 5(9), 685.
(2017). A Methodological Framework for Meta-analysis and Clinical Interpretation of Subgroup Data: The Case of Major Adverse Cardiovascular Events With GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 2 Diabetes..
Diabetes Care. 47(2), 184-192.
(2024). Most add-on therapies to metformin have similar effects on HbA1c..
Evid Based Med. 21(6), 223.
(2016). Once-weekly dipeptidyl peptidase-4 inhibitors for type 2 diabetes: a systematic review and meta-analysis..
Expert Opin Pharmacother. 18(9), 843-851.
(2017). Once-weekly dipeptidyl peptidase-4 inhibitors for type 2 diabetes: a systematic review and meta-analysis.
Expert Opinion on Pharmacotherapy. 18555857646565(9111111), 843 - 851.
(2017). Premixed insulin regimens for type 2 diabetes.
Endocrine. 5128136293852682932172681092030295868(321Suppl 2811036512641555321), 387 - 389.
(2016).
(2023). Racial, ethnic and sex disparities among participants in cardiovascular outcomes trials in type 2 diabetes: A systematic review and descriptive analysis..
Diabetes Obes Metab. 25(2), 618-622.
(2023). Safety of dipeptidyl peptidase 4 inhibitors: a perspective review..
Ther Adv Drug Saf. 5(3), 138-46.
(2014). Semaglutide for type 2 diabetes mellitus: a systematic review and meta-analysis.
Diabetes, Obesity and Metabolism.
(2018). Semaglutide for type 2 diabetes mellitus: A systematic review and meta-analysis..
Diabetes Obes Metab. 20(9), 2255-2263.
(2018). A simple plaster for screening for diabetic neuropathy: a diagnostic test accuracy systematic review and meta-analysis..
Metabolism. 63(4), 584-92.
(2014). Socioeconomic aspects of incretin-based therapy..
Diabetologia. 66(10), 1859-1868.
(2023). Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes: a systematic review and meta-analysis..
Ann Intern Med. 159(4), 262-74.
(2013). Sotagliflozin for patients with type 2 diabetes: A systematic review and meta-analysis..
Diabetes Obes Metab. 24(1), 106-114.
(2022). Systematic review and meta-analysis of vildagliptin for treatment of type 2 diabetes.
Endocrine. 458 - 480.
(2016). Ultra-rapid-acting insulins for adults with diabetes: A systematic review and meta-analysis..
Diabetes Obes Metab. 23(10), 2395-2401.
(2021). Update on long-term efficacy and safety of dapagliflozin in patients with type 2 diabetes mellitus..
Ther Adv Endocrinol Metab. 6(2), 61-7.
(2015).
(2016).
(2016).